Serum Institute Of India Applies To Drug Authority To Manufacture Covid Vaccine Sputnik V: Report
The Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture COVID-19 vaccine Sputnik V in the country, sources said today.
The Pune-based vaccine manufacturing firm has also sought approval for test analysis and examination.
Russia’s Sputnik V vaccine is currently being manufactured in India by Dr Reddy’s Laboratories.
“The Serum Institute of India (SII) put up an application to the Drugs Controller General of India (DCGI) on Wednesday seeking permission to manufacture the COVID-19 vaccine, Sputnik V, in India,” a source told news agency Press Trust of India.
The Serum Institute of India has already told the government that it will be able to manufacture and supply 10 crore Covishield doses in June, while it is also manufacturing the Novavax vaccine, the regulatory clearance for which is awaited from the United States.
The vaccine was given emergency use authorisation (EUA) by the Drug Controller General of India in April.
A consignment of 30 lakh doses of Sputnik V arrived in Hyderabad on Tuesday.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)